Is It Too Late to Buy Viking Therapeutics Stock? | Nasdaq

17 hours ago · The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Viking Therapeutics wasn’t one of them. The 10 stocks that ...

CouponFollow Extension

54%
OFF

Is It Too Late To Buy Viking Therapeutics Stock?

1 week from now

Apr 6, 2024 · NASDAQ: VKTX Viking Therapeutics. Market Cap. $8B. Today's Change (-0.54%) -$0.37 ... Despite its meteoric share price rise, I do not think it's too late to buy Viking …

fool.com

260%
OFF

Is It Too Late To Buy Viking Therapeutics Stock? - Yahoo Finance

1 week from now

May 22, 2024 · Is It Too Late to Buy Viking Therapeutics Stock? Alex Carchidi, The Motley Fool . Wed, May 22, 2024, ... Up 260% so far this year, shares of Viking Therapeutics (NASDAQ: …

yahoo.com

528%
OFF

Is Viking Therapeutics Stock A Buy? - Nasdaq

1 week from now

Mar 11, 2024 · With Viking Therapeutics (NASDAQ: VKTX) stock exploding skyward by 528% over the last 12 months, it's easy to wonder if the opportunity to buy its stock is too good to be …

nasdaq.com

120%
OFF

Viking Therapeutics Just Soared 120% On Optimism ... - The …

1 week from now

Feb 29, 2024 · Too Late to Buy? By Adria Cimino ... NASDAQ: VKTX Viking Therapeutics. Market Cap. $6B. Today's Change ... 4 Reasons Why Buying Viking Therapeutics Stock Right Now Is …

fool.com

0%
OFF

Chartwell Investment Partners LLC Acquires 17,159 Shares Of …

1 week from now

5 days ago · Chartwell Investment Partners LLC grew its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 88.0% during the third quarter, according to the …

marketbeat.com

$96
OFF

Market Whales And Their Recent Bets On VKTX Options

1 week from now

3 days ago · 2 market experts have recently issued ratings for this stock, with a consensus target price of $96.0. ... an analyst from HC Wainwright & Co. keeps a Buy rating on Viking …

benzinga.com

1%
OFF

Aptus Capital Advisors LLC Purchases 9,699 Shares Of Viking ...

1 week from now

4 days ago · Aptus Capital Advisors LLC lifted its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 34.1% in the third quarter, according to the company in its …

marketbeat.com

71%
OFF

5 Things You Need To Know If You Buy Viking Therapeutics Stock …

1 week from now

Mar 28, 2024 · If we limit the list only to those with market caps of at least $500 million, it's Viking Therapeutics (VKTX-2.71%). So far in 2024, Viking's shares have skyrocketed over 270% …

fool.com

531%
OFF

Got $5,000? Viking Therapeutics Stock Just Got A Big New Green …

1 week from now

Nov 7, 2024 · With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (VKTX-0.51%) are a hot commodity, to say the least. And as of early November, …

fool.com

10%
OFF

Eli Lilly Falls More Than 10% In A Month: Buy, Sell Or Hold

1 week from now

6 days ago · Several companies like Amgen AMGN, Viking Therapeutics are making rapid progress in the development of GLP-1-based candidates in their clinical pipeline. These can …

nasdaq.com

FAQs about Is It Too Late to Buy Viking Therapeutics Stock? | Nasdaq Coupon?

Is it too late to buy Viking Therapeutics stock?

In conclusion, no, it is not too late to buy Viking Therapeutics stock. Just be aware that the road to commercializing its first medicine is probably slightly riskier than some may believe, and be ready to hold onto your shares for a few years while its clinical trials play out. Alex Carchidi has no position in any of the stocks mentioned. ...

Should you buy Viking Therapeutics (vktx)?

Up 260% so far this year, shares of Viking Therapeutics ( VKTX -1.90%) are a hot commodity thanks to its increasingly promising therapies in development to treat obesity. But as wise investors know, buying a small biotech stock immediately after it has significantly gained in value can be a especially risky proposition. ...

Should you buy Viking Therapeutics?

Viking Therapeutics Just Soared 120% on Optimism About Its Weight Loss Candidate. Too Late to Buy? Investors are excited about Viking’s prospects in what may become a $100 billion market. The biotech just reported positive results from a clinical trial of its weight loss drug candidate -- one aiming to compete with market leaders. ...

Did investors miss a chance to get in on Viking Therapeutics?

In the wake of that news, shares surged, and they are now up more than 300% year to date. With that big share price move in the rear-view mirror, have investors missed their chance to get in on the next big player in weight loss? Viking Therapeutics stock is on a roll, but... ...

Does Viking Therapeutics have a liquidity problem?

Viking Therapeutics is still a clinical-stage company -- none of its products has been approved by regulators for commercialization and sale. Because it's a pre-revenue business that is investing heavily in research and development, liquidity could be a real issue. VKTX Net Income (Quarterly) data by YCharts. ...

Is Viking Therapeutics overvalued?

One (very) imperfect way to determine whether Viking Therapeutics is overvalued is to compare it with other mid-cap drugmakers. CRISPR Therapeutics is a company that already has a product on the market, yet its market capitalization is only $4.2 billion, about $2 billion lower than Viking's. ...